1-benzyl-2-ethyl-1H-pyrrole | 240416-68-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯
• 英文名称: 1-benzyl-2-ethyl-1H-pyrrole
• 英文别名: 1-benzyl-2-ethylpyrrole
• CAS: 240416-68-6
• 化学式: C₁₃H₁₅N
• 分子量: 185.269
• InChiKey: KXESVYGKEUSGKX-UHFFFAOYSA-N

物化性质

• 沸点：
  284.4±9.0 °C(Predicted)
• 密度：
  0.95±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  4.9
• 氢给体数：
  0
• 氢受体数：
  0

反应信息

• 作为反应物：
  描述：

  1-benzyl-2-ethyl-1H-pyrrole 在 三氯氧磷 作用下， 以 四氢呋喃 为溶剂， 反应 19.5h， 以56%的产率得到1-benzyl-5-ethyl-1H-pyrrole-2-carbaldehyde
  参考文献：
  名称：

  WO2007/56184

  摘要：

  公开号：
• 作为产物：
  描述：

  4-Benzotriazol-1-yl-1-benzylamino-hex-5-en-2-ol 在 aluminum oxide 、 palladium diacetate 、 potassium carbonate 、 三苯基膦 作用下， 以 甲醇 为溶剂， 反应 24.0h， 生成 1-benzyl-2-ethyl-1H-pyrrole
  参考文献：
  名称：

  Palladium-Catalyzed Reactions of N-Allylbenzotriazoles with Amines:  Intramolecular Allylamination Routes to 2-Vinylpyrrolidines and 2-Vinylpiperidines

  摘要：

  Reactions of allylbenzotriazole (4a-d) with 1-bromo-3-chloropropane, 1-bromo-2-methyl-3-chloropropane, epibromohydrin (8), and 1-bromo-4-chlorobutane afforded the corresponding alpha-substituted allylbenzotriazoles (5a-d, 9, and 16a,b), which with primary amines in one-pot sequences produce 2-vinylpyrrolidines (7a-i), 2-ethylpyrrole (13), and 2-vinylpiperidines (18a-c) in good yields under mild conditions.

  DOI：

  10.1021/jo990181r

文献信息

• Palladium‐Catalyzed Regioselective Dehydrogenative C–H/C–H Cross‐Coupling of Pyrroles and Pyridine <i>N</i> ‐Oxides
  作者：Shanshan Liu、C. Christoph Tzschucke

  DOI：10.1002/ejoc.201600680

  日期：2016.7

  The palladium-catalyzed cross-dehydrogenative coupling of N-alkylpyrroles and pyridine N-oxides gave the corresponding pyrrolylpyridine N-oxides. Cu(OAc)2·H2O as a co-catalyst with air as the terminal oxidant led to preferential coupling in the β-position, whereas AgOAc as the stoichiometric oxidant resulted in preferential coupling in the α-position. N-(Benzyloxymethyl)pyrrole derivatives were deprotected

  N-烷基吡咯和吡啶N-氧化物的钯催化交叉脱氢偶联得到相应的吡咯基吡啶N-氧化物。Cu(OAc)2·H2O作为助催化剂，空气作为末端氧化剂导致β位优先偶联，而化学计量氧化剂AgOAc导致α位优先偶联。N-(苄氧基甲基)吡咯衍生物通过氢解和碱水解脱保护。
• Multivalent indole compounds and use thereof as phospholipase-A2 inhibitors
  申请人：Chang Han-Ting

  公开号：US20070135385A1

  公开（公告）日：2007-06-14

  Indole and indole-related compounds, compositions and methods are disclosed. The compounds of the invention are useful as phospholipase inhibitors. The compounds and compositions of the invention are useful for treatment of phospholipase-related conditions, such as insulin-related, weight-related and/or cholesterol-related conditions in an animal subject.

  吲哚和与吲哚相关的化合物、组合物以及方法被披露。发明中的这些化合物作为磷脂酶抑制剂非常有用。发明中的这些化合物和组合物用于治疗动物受试者中的磷脂酶相关状况，例如胰岛素相关、体重相关和/或胆固醇相关状况。
• Derivatives of Heptaazaphenalene, Methods for Obtaining Them, and Their Use as Protecting Agents Against Uv Radiation
  申请人：Trullas Carles

  公开号：US20080193398A1

  公开（公告）日：2008-08-14

  The present invention relates to new heptaazaphenalene derivatives of general Formula (I) and to methods for obtaining them. The physicochemical properties of said compounds allow them to be used as UV radiation absorbents.

  本发明涉及一种新的一氮七环苯衍生物，其一般化学式为（I），以及获取它们的方法。所述化合物的物理化学性质使其可以用作紫外辐射吸收剂。
• AZAINDOLE COMPOUNDS AND USE THEREOF AS PHOSPHOLIPASE-A2 INHIBITORS
  申请人：Chang Han-Ting

  公开号：US20090239896A1

  公开（公告）日：2009-09-24

  Indole and indole-related compounds, compositions and methods are disclosed. The compounds of the invention are useful as phospholipase inhibitors. The compounds and compositions of the invention are useful for treatment of phospholipase-related conditions, such as insulin-related, weight-related and/or cholesterol-related conditions in an animal subject. The compounds include azaindoles of the formula below [insert FIG. 6 c ] in which at least one of CR4, CR5, CR6 and CR7 is replaced by N, and the groups R1-R7 are defined as in claim 1.

  本发明涉及吲哚及其相关化合物、组合物和方法。本发明的化合物可用作磷脂酶抑制剂。本发明的化合物和组合物可用于治疗磷脂酶相关疾病，例如动物主体中的胰岛素相关、体重相关和/或胆固醇相关疾病。化合物包括以下式子中的氮杂吲哚[插入FIG.6c]，其中CR4、CR5、CR6和CR7中的至少一个被N替换，且R1-R7基团如权利要求1所定义。
• Phospholipase inhibitors, including multi-valent phospholipase inhibitors, and use thereof, including as lumen-localized phospholipase inhibitors
  申请人：Chang Han-Ting

  公开号：US20070135383A1

  公开（公告）日：2007-06-14

  The present invention provides methods and compositions for the treatment of phospholipase-related conditions. In particular, the invention provides a method of treating insulin-related, weight-related conditions and/or cholesterol-related conditions in an animal subject. The method generally involves the administration of a non-absorbed and/or effluxed phospholipase A2 inhibitor that is localized in a gastrointestinal lumen.

  本发明提供了治疗磷脂酶相关疾病的方法和组合物。具体地，本发明提供了一种用于治疗动物主体中的胰岛素相关、体重相关和/或胆固醇相关疾病的方法。该方法通常涉及在胃肠道腔中定位的非吸收和/或外流的磷脂酶A2抑制剂的给药。